Cabaletta Bio (CABA) Total Liabilities (2018 - 2026)

Cabaletta Bio's Total Liabilities history runs 8 years deep, the most recent figure standing at $53.0 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 62.12% year-over-year to $53.0 million; the TTM figure through Dec 2025 stood at $53.0 million (up 62.12% YoY), while the FY2025 annual figure was $53.0 million, up 62.12% from the prior year.
• Total Liabilities for Q4 2025 stood at $53.0 million, up from $50.3 million in the prior quarter.
• The five-year high for Total Liabilities was $122.6 million in Q3 2021, with the low at $8.4 million in Q4 2021.
• The 5-year median for Total Liabilities is $38.1 million (2024), against an average of $50.5 million.
• The sharpest annual moves came in 2021 and 2025: Total Liabilities plunged 92.7% in 2021, then surged 157.1% in 2025.
• Cabaletta Bio's Total Liabilities stood at $8.4 million in 2021, then surged by 48.54% to $12.4 million in 2022, then jumped by 40.2% to $17.5 million in 2023, then soared by 87.43% to $32.7 million in 2024, then jumped by 62.12% to $53.0 million in 2025.
• Business Quant data shows CABA's Total Liabilities at $53.0 million in Q4 2025, $50.3 million in Q3 2025, and $46.0 million in Q2 2025.